References
- Chou ST, Westhoff CM. The Rh and RhAG blood group systems. Immunohematology 2010;26:178–86.
- Flegel WA. Molecular genetics of RH and its clinical application. Transfus Clin Biol 2006;13:4–12.
- Li X, Jayachandran S, Nguyen HH, Chan MK. Structure of the Nitrosomonas europaea Rh protein. Proc Nat Acad Sci U S A 2007;104:19279–84.
- Lupo D, Li X, Durand A, et al. The 1.3-Å resolution structure of Nitrosomonas europaea Rh50 and mechanistic implications for NH3 transport by Rhesus family proteins. Proc Nat Acad Sci U S A 2007;104:19303–8.
- Gruswitz F, Chaudhury S, Ho JD, et al. Function of human Rh based on structure of RhCG at 2.1 Å. Proc Nat Acad Sci U S A 2010;9638–43.
- Silvy M, Chapel-Hernandes S, Callebaut I, et al. Characterization of novel RHD alleles: relationship between phenotype, genotype, and trimeric architecture. Transfusion 2012;52:2020–9.
- De Brevern AG, Floch A, Barrault A, et al. Alloimmunization risk associated with amino acid 223 substitution in the RhD protein: analysis in the light of molecular modeling. Transfusion 2018;58:2683–92.
- Vallese F, Kim K, Yen LY, et al. Architecture of the human erythrocyte ankyrin-1 complex. Nat Struct Mol Biol 2022; 29:706–18.
- Floch A, Galochkina T, Pirenne F, Tournamille C, de Brevern AG. Molecular dynamics of the human RhD and RhAG blood group proteins. Front Chem 2024;12:1360392.
- Floch A, Pirenne F, Barrault A, et al. Insights into anti-D formation in carriers of RhD variants through studies of 3D intraprotein interactions. Transfusion 2021;61:1286–301.
- Trueba-Gómez R, Rosenfeld-Mann F, Baptista-González HA, Domínguez-López ML, Estrada-Juárez H. Use of computational biology to compare the theoretical tertiary structures of the most common forms of RhCE and RhD. Vox Sang 2023;118:881–90.
- Nicolas V, Mouro-Chanteloup I, Lopez C, et al. Functional interaction between Rh proteins and the spectrin-based skeleton in erythroid and epithelial cells. Transfus Clin Biol 2006;13:23–8.
- Blanc M, David F, Abrami L, et al. SwissPalm: protein palmitoylation database. F1000Res 2015;4:261. Release 5, 2025. Available from https://swisspalm.org. Accessed 27 May 2025.
- Daniels G. Human blood groups. 3rd ed. Oxford: Wiley-Blackwell, 2013:182–258.
- Daniels G. Variants of RhD—current testing and clinical consequences. Br J Haematol 2013;161:461–70.
- Mazières S, Condemi S, El Nemer W, Chiaroni J. Rapid change in red cell blood group systems after the main Out of Africa of Homo sapiens. Sci Rep 2025;15:1597.
- Blancher A, Socha WW. The Rhesus system. In: Blancher A, Klein J, Socha WW, Eds. Molecular biology and evolution of blood group and MHC antigens in primates. Berlin: Springer-Verlag, 1997:147-218.
- Anstee DJ. The relationship between blood groups and disease. Blood 2010;115:4635–43.
- Flegr J, Toman J, Hůla M, Kaňková S. The role of balancing selection in maintaining human RhD blood group polymorphism: a preregistered cross-sectional study. J Evol Biol 2021;34:426–38.
- Bruun-Rasmussen P, Dziegiel MH, Banasik K, Johansson PI, Brunak S. Associations of ABO and Rhesus D blood groups with phenome-wide disease incidence: a 41-year retrospective cohort study of 482,914 patients. eLife 2023;12:e83116.
- International Society of Blood Transfusion. RHD blood group alleles. v6.4. Red cell immunogenetics and blood group terminology. Amsterdam: International Society of Blood Transfusion, 2023. Available from https://www.isbtweb.org/resource/004rhd.html. Accessed 26 May 2025.
- Wagner FF, Flegel WA. The Rhesus site. Transfus Med Hemother 2014;41:357-63. Human RhesusBase version 2.5.2. 18 March 2020. Available from https://www.rhesusbase.info/. Accessed 26 May 2025.
- Floch A, Téletchéa S, Tournamille C, de Brevern AG, Pirenne F. A review of the literature organized into a new database: RHeference. Transfus Med Rev 2021;35:70–7. Available from https://www.rheference.org. Accessed 26 May 2025.
- Tippett P, Lomas-Francis C, Wallace M. The Rh antigen D: partial D antigens and associated low incidence antigens. Vox Sang 1996;70:123–31.
- Sandler SG, Flegel WA, Westhoff CM, et al. It’s time to phase in RHD genotyping for patients with a serologic weak D phenotype. Transfusion 2015;55:680–9.
- Flegel WA, Denomme GA, Queenan JT, et al. It’s time to phase out “serologic weak D phenotype” and resolve D types with RHD genotyping including weak D type 4. Transfusion 2020;60:855–9.
- Ramsey G, Park YA, Eder AF, et al. Obstetric and newborn weak D-phenotype RBC testing and Rh immune globulin management recommendations: lessons from a blinded specimen-testing survey of 81 transfusion services. Arch Pathol Lab Med 2023;147:71-8.
- Theiler C, Lomas-Francis C, Vege S, et al. Weak and partial D phenotyping: a comparison study between molecular and serologic results. Immunohematology 2024;40:159–65.
- Denomme G, Dake LLR, Vilensky D, Ramyar L, Judd WJ. Rh discrepancies caused by variable reactivity of partial and weak D types with different serologic techniques. Transfusion 2008; 48:473–8.
- Avent ND. New insight into the Rh system: structure and function. ISBT Sci Ser 2007;2:35–45.
- Fennell K, Hoffman R, Yoshida K, et al. Effect on gene expression of three allelic variants in GATA motifs of ABO, RHD, and RHCE regulatory elements. Transfusion 2017;57:2804–8.
- McGowan EC, Wu PC, Hellberg Å, Lopez GH, Hyland CA, Olsson ML. A bioinformatically initiated approach to evaluate GATA1 regulatory regions in samples with weak D, Del, or D-phenotypes despite normal RHD exons. Transfus Med Hemother 2024;51:252–64.
- Li Q, Hou L, Guo Z, Ye L, Yue D, Zhu Z. Molecular basis of the RHD gene in blood donors with DEL phenotypes in Shanghai. Vox Sang 2009;97:139–46.
- Christiansen M, Sørensen BS, Grunnet N. RHD positive among C/E+ and D- blood donors in Denmark. Transfusion 2010;50:1460–4.
- Wagner FF, Gassner C, Müller TH, Schönitzer D, Schunter F, Flegel WA. Molecular basis of weak D phenotypes. Blood 1999;93:385–93.
- Flegel WA, von Zabern I, Wagner FF. Six years’ experience performing RHD genotyping to confirm D– red blood cell units in Germany for preventing anti-D immunizations. Transfusion 2009;49:465-71.
- Trueba-Gómez R, Rosenfeld-Mann F, Estrada-Juárez H. Prediction of the antigenic regions in eight RhD variants identified by computational biology. Vox Sang 2024;119:590–7.
- Lejon Crottet S, Haer-Wigman L, Gowland P, Fontana S, Niederhauser C, Hustinx H. Serologic and molecular investigations of DARI (weak D type 4.2), DARI.2, DAR1.3, DAR2 (DARE), and DARA. Transfusion 2013;53:3000–8.
- Srivastasa K, Polin H, Sheldon SL, et al. The DAU cluster: a comparative analysis of 18 RHD alleles, some forming partial D antigens. Transfusion 2016;56:2520–31.
- Roussel M, Poupel S, Nataf J, et al. RHD*DOLl and RHD*DOL2 encode a partial D antigen and are in cis with the rare RHCE*ceBI allele in people of African descent. Transfusion 2013;53:363–72.
- Wagner FF, Frohmajer A, Flegel WA. RHD positive haplotypes in D negative Europeans. BMC Genet 2001;2:10.
- Fichou Y, Gehannin P, Corre M, et al. Extensive functional analyses of RHD splice site variants: insights into the potential role of splicing in the physiology of Rh. Transfusion 2015;55:1432–43.
- Ogasawara K, Sasaki K, Isa K, et al. Weak D alleles in Japanese: a c.960G>A silent mutation in exon 7 of the RHD gene that affects D expression. Vox Sang 2016;110:179–84.
- Raud L, Le Tertre M, Vigneron L, et al. Missense RHD single nucleotide variants induce weakened D antigen expression by altering splicing and/or protein expression. Transfusion 2021;61:2468–76.
- Floch A, Vege S, Berardi P, et al. An intron c.149-2632T>A change in RHD is associated with aberrant transcription and very weak D phenotype. Transfusion 2022;62:E14–6.
- Fichou Y. Hybrids and microconversions in RH genes: investigation and implication in transfusion therapy. Ann Blood 2023;8:7.
- Flegel WA, Eicher NI, Doescher A, et al. In-frame triplet deletions in RHD alter the D antigen phenotype. Transfusion 2006;46:2156–61.
- Flegel WA, Srivastava K. Frameshift variations in the RHD coding sequence: molecular mechanisms permitting protein expression. Transfusion 2020;60:2737–44.
- Wagner FF. Serology and molecular biology of DEL: a narrative review. Ann Blood 2023;8:28.
- Fichou Y, Parchure D, Gogri H, et al. Molecular basis of weak D expression in the Indian population and report of a novel, predominant variant RHD allele. Transfusion 2018;58: 1540–9.
- Richard M, Perrault J, Constanzo-Yanez J, Khalifé S, St-Louis M. A new DEL variant caused by exon 8 deletion. Transfusion 2007;47:852–7.
- Srivastava K, Stiles DA, Wagner FF, Flegel WA. Two large deletions extending beyond either end of the RHD gene and their red cell phenotypes. J Hum Genet 2018;63:27–35.
- Tsunemaya H, Isa K, Ogasawara K, et al. Identification of a mutation in the RHAG gene of Japanese with weak D phenotype. Transfusion 2013;53(Suppl 2):167A.
- Wen J, Verhagen OJHM, Jia S, et al. A variant RhAG protein encoded by the RHAG*572A allele causes serological weak D expression while maintaining normal RhCE phenotypes. Transfusion 2019;59:405–11.
- Satchwell TJ, Bell AJ, Hawley BR, et al. Severe ankyrin-R deficiency results in impaired surface retention and lysosomal degradation of RhAG in human erythroblasts. Haematologica 2016;101:1018–27.
- Shao CP, Maas JH, Su YQ, Köhler M, Legler TJ. Molecular background of Rh D-positive, D-negative, Del and weak D phenotypes in Chinese. Vox Sang 2002;83:156-61.
- Tilley L. An update on the RHAG blood group system. Immunohematology 2025;41:1–3. DOI: 10.2478/immunohematology-2025-002.
- Vege S, Floch A. An update on the Rh blood group system: RHCE. Immunohematology (in press).
- Denomme GA, Wang D, Matheson KA, Titolo D. The proximal cis-regulatory region of the RHD/RHCE promoter is 105 bp and contains a 55-bp core devoid of known binding motifs but necessary for transcription. Transfusion 2009;49:1361–9.
- Pham BN, Roussel M, Peyrard T, et al. Anti-D investigations in individuals expressing weak D type 1 or weak D type 2: alio- or autoantibodies? Transfusion 2011;51:2679–85.
- Morin P, Perrault J, St-Louis M, Leiva-Torres GA, Robitaille N, Trépanier P. Weak D type 42: antigen density and risk of alloimmunization in the province of Québec. Vox Sang 2022;117:943–8.
- Raud L, Ka C, Gourlaouen I, et al. Functional analysis of novel RHD variants: splicing disruption is likely to be a common mechanism of variant D phenotype. Transfusion 2019;59:1367–75.
- Matzhold EM, Polin H, Körmöczi G, et al. RHD del28Phe (DMW) encoded by a novel in-frame deletion resulting in reduced D antigen expression. Transfusion 2019;59:3033–4.
- Pereira J, Rodrigues M J, Tilley L, et al. RhD variant caused by an in-frame triplet duplication in the RHD gene. Transfusion 2011;51:570–3.
- Tilley L, Rodrigues MJ, Malde R, et al. Two novel RhD variants caused by triplet deletions in the RhD gene. Transfusion Med 2007;17(Suppl 1):31.
- Gassner C, Doescher A, Drnovsek TD, et al. Presence of RHD in serologically D-, C/E+ individuals: a European multicenter study. Transfusion 2005;45:527–38.
- Nogues N, Tarrago M, Subirana L, et al. RHD null alleles in the Spanish population. Vox Sang 2007;93(Suppl 1):205.
- Lopez GH, Turner RM, McGowan EC, et al. A DEL phenotype attributed to RHD exon 9 sequence deletion: slipped-strand mispairing and blood group polymorphisms. Transfusion 2018;58:685–91.
- Fichou Y, Chen J, Le Maréchal C, et al. Weak D caused by a founder deletion in the RHD gene. Transfusion 2012;52: 2348–55.
- International Society of Blood Transfusion. RHAG blood group alleles. v6.4. Red cell immunogenetics and blood group terminology. 2023. Available from https://www.isbtweb.org/resource/030rhag.html. Accessed 26 May 2025.
- Hartel-Schenk S, Agre P. Mammalian red cell membrane Rh polypeptides are selectively palmitoylated subunits of a macromolecular complex. J Biol Chem 1992;267:5569–74.
- Blaskovic S, Blanc M, Gisou van der Goot F. What does S-palmitoylation do to membrane proteins? FEBS J 2013; 280:2766–74.
- Mesquita FS, Abrami L, Linder ME, Bamji SX, Dickinson BC, Gisou van der Goot F. Mechanisms and functions of protein S-acylation. Nat Rev Molec Cell Biol 2024;25:488–509.
- Łach A, Gryzbek M, Heger E, et al. Palmitoylation of MPP1 (membrane-palmitoylated proteinl)/p55 is crucial for lateral membrane organization in erythroid cells. J Biol Chem 2012;287:18974–84.
- Łach A, Gryzbek M, Heger E, et al. Withdrawal: palmitoylation of MPP1 (membrane-palmitoylated proteinl)/p55 is crucial for lateral membrane organization in erythroid cells. J Biol Chem 2018;293:2786.
- Yazer MH, Triulzi DJ, Sperry JL, Seheult JN. Rate of RhD-alloimmunization after the transfusion of multiple RhD-positive primary red blood cell-containing products. Transfusion 2021;61(Suppl l):S150–8.
- Seheult JN, Callum J, Delaney M, et al. Rate of D- alloimmunization in trauma does not depend on the number of RhD-positive units transfused: the BEST collaborative study. Transfusion 2022;62(Suppl l):S185–92.
- Ji Y, Luo G, Fu Y. Incidence of anti-D alloimmunization in D-negative individuals receiving D-positive red blood cell transfusion: a systematic review and meta-analysis. Vox Sang 2022;117:633–40.
- Hubert T, Kerkhoffs JL, Brand A, Schonewille H. Anti-D immunization after D positive platelet transfusions in D negative recipients: a systematic review and meta-analysis. Transfusion 2024;64:933–45.
- Perez-Alvarez I, Hayes C, Hailemariam T, Shin E, Hutchinson T, Klapper E. RHD genotyping of serologic RhD-negative blood donors in a hospital-based blood donor center. Transfusion 2019;59:2422–8.
- Pardi C, Hellberg Å, Isakson P. Single-exon fetal RHD genotyping: a 31-month follow up in the obstetric population of Western Sweden. Blood Transfus 2024;22:387–94.
- Krog GR, Clausen FB, Berkowicz A, et al. Is current serologic RhD typing of blood donors sufficient for avoiding immunization of recipients? Transfusion 2011;51:2278–85.
- Stegmann TC, Veldhuisen B, Bijman R, et al. Frequency and characterization of known and novel RHD variant alleles in 37 782 Dutch D-negative pregnant women. Br J Haematol 2016;173:469–79.
- Crottet SL, Henny C, Meyer S, et al. Six years’ experience performing RHD genotyping to confirm D- red blood cell units in Germany for preventing anti-D immunizations. Transfus Apher Sci 2014;50:169–74.
- Polin H, Danzer M, Gaszner W, et al. Identification of RHD alleles with the potential of anti-D immunization among seemingly D- blood donors in Upper Austria. Transfusion 2009;49:676-81.
- Orzińska A, Guz K, Polin H, et al. RHD variants in Polish blood donors routinely typed as D negative. Transfusion 2013;53(Suppl 2):2945-53.
- Vendrame TAP, Arnoni CP, Muniz JG, et al. Characterization of RHD alleles present in serologically R HD-negative donors determined by a sensitive microplate technique. Vox Sang 2019;114:869–75.
- Trucco Boggione C, Luján Brajovich ME, Tarragó M, et al. Molecular structures identified in serologically D- samples of an admixed population. Transfusion 2014;54:2456–62.
- Ye S, Wu D, Wang M, et al. A comprehensive investigation of RHD polymorphisms in the Chinese Han population in Xi'an. Blood Transfus 2014;12:396–404.
- Thongbut J, Laengsri V, Raud L, et al. Nation-wide investigation of RHD variants in Thai blood donors: impact for molecular diagnostics. Transfusion 2021;61:931–8.
- Kim JY, Kim SY, Kim C, Yon GS, Park SS. Molecular characterization of D- Korean persons: development of a diagnostic strategy. Transfusion 2005;45:345–52.
- Ogasawara K, Suzuki Y, Sasaki K, et al. Molecular basis for D- Japanese: identification of novel DEL and D- alleles. Vox Sang 2015;109:359–65.
- Flegel WA, Srivastava K. 40 Years of researching the Del phenotype results in a change of transfusion practice. Transfusion 2024;64:1187–90.
- Hess JR. Safe transfusion in Asian-type DEL. Blood 2023:141:2044–6.
- Bowman J. Thirty-five years of Rh prophylaxis. Transfusion 2003;43:1661–6.
- Pegoraro V, Urbinati D, Visser GHA, et al. Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: a preventable disease that still produces significant morbidity and mortality in children. PLoS ONE 2020;15:e0235807.
- Luo X, Keller M A, James I, et al. Strategies to identify candidates for D variant genotyping. Blood Transfus 2018;16:293–301.
- Horn TN, Keller J, Keller MA, Klinger L. Identifying obstetrics patients in whom RHD genotyping can be used to assess risk of D alloimmunization. Immunohematology 2020;36:146–51.
- Arnoni CA, Vendrame TA, Silva FS, et al. Serologic profiling of D variants in donor routine: unveiling the impact on false-negative results and alloimmunization. Immunohematology 2024;40:47–53.
- Ramsey G, Barriteau CM. Estimating the serological under-recognition of patients with weak or partial RHD variants. Transfusion 2024;64:920–8.
- Barriteau CM, Lindholm PL, Hartman K, Sumugod RD, Ramsey G. RHD genotyping to resolve weak and discrepant RhD patient phenotypes. Transfusion 2022;62:2194–9.
- Londero D, Monge J, Hellberg A. A multi-centre study on the performance of the molecular genotyping platform ID RHD XT for resolving serological weak RhD phenotype in routine clinical practice. Vox Sang 2020;115:241–8.
- Westhoff CM, Floch A. Blood group genotype matching for transfusion. Br J Haematol 2025;206:18–32.
- Vege S, Sprogøe U, Lomas-Francis C, et al. Impact of RHD genotyping on transfusion practice in Denmark and the United States and identification of novel RHD alleles. Transfusion 2021;61:256–65.
- Madgett TE, Tounsi WA, Halawani AJ, Avent ND. RHD molecular analysis: from discovery to next generation sequencing. Ann Blood 2023;8:36.
- Khandelwal A, Zittermann S, Sierocinski T, Montemayor C. RH genotyping by next-generation sequencing. Ann Blood 2023;8:39.
- Lane WJ, Westhoff CM, Gleadall NS, et al. Automated typing of red blood cell and platelet antigens; a whole-genome sequencing study. Lancet Haematol 2018;5:e241–51.
- Halls JBL, Vege S, Simmons DP, et al. Overcoming the challenges of interpreting complex and uncommon RH alleles from whole genomes. Vox Sang 2020;115:790–801.
- Chen S, Francioli LC, Goodrich JK, et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature 2024;625:92–100.
- The All of Us Research Program Genomics Investigators. Genomic data in the All of Us research program. Nature 2024;627:340–6.
- Fung-Kee-Fung K, Wong K, Walsh J, Hamel C, Clarke G. Guideline no. 448: prevention of Rh D alloimmunization. J Obstet Gynaecol Can 2024;46:102449.
- Westhoff CM, Nance S, Lomas-Francis C, Keller M, Chou ST. Experience with RHD*weak D type 4.0 in the USA. Blood Transfus 2019;17:91–3.
- Miranda MR, Delfino dos Santos T, Castilho L. Systematic RHD genotyping in Brazilians reveals a high frequency of partial D in transfused patients serologically typed as weak D. Transfus Apher Sci 2021;60:103235.
- Jenkins CM, Johnson ST, Bellissimo DB, Gottschall JL. Incidence of weak D in blood donors typed as D positive by the Olympus PK 7200. Immunohematology 2005;21:152–4.
- Haspel RL, Westhoff CM. How do I manage Rh typing in obstetric patients? Transfusion 2015;55:470–4.
- Mamone L, James IL, Yoon EJ, Alsammak M. Clinical and cost efficacy of molecular RhD genotyping. Transfusion 2018;58(Suppl 2):178A.
- Uzuni A, Wlosinski L, Lopez-Plaza I. Updated evaluation of RhD status among women of child-bearing age in Detroit, Michigan. Am J Clin Pathol 2021;156:1000–6.
- Hudgins JP, Matsushita C, Tuma CW, O’Brien L, Shulman IA. Identification of RHD allelic variants discovered by atypical typing results on the NEO/Echo platforms. Immunohematology 2021;37:165–70.
- Keller MA. RH genetic variation and the impact for typing and personalized transfusion strategies: a narrative review. Ann Blood 2023;8:18.
- Denomme GA, Wagner FF, Fernandes BJ, Li W, Flegel WA. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention. Transfusion 2005;45:1554–60.
- Clarke G, Hannon J, Berardi P, et al. Resolving variable maternal D typing using serology and genotyping in selected prenatal patients. Transfusion 2016;56:2980–5.
- Leiva-Torres GA, Chevrier M, Constanzo-Yanez J, et al. High prevalence of weak D type 42 in a large-scale RHD genotyping program in the province of Quebec (Canada). Transfusion 2021;61:2727–35.
- Polin H, Danzer M, Hofer K, Gassner W, Gabriel C. Effective molecular RHD typing strategy for blood donations. Transfusion 2007;47:1350–5.
- Juhl D, Luckner K, Brockmann C, et al. RHD-negative red cells may be avoided for patients with ambiguous serologic typing for the RHD antigen. Transfusion 2024;64:281–8.
- Müller TH, Wagner FF, Trockenbacher A, et al. PCR screening for common weak D types shows different distributions in three Central European populations. Transfusion 2001;41: 45–52.
- Fichou Y, Le Maréchal C, Jamet D, et al. Establishment of a medium-throughput approach for the genotyping of RHD variants and report of nine novel rare alleles. Transfusion 2013;53:1821–8.
- Van Sandt VST, Gassner C, Emonds M, Legler TJ, Mahieu S, Körmöczi GF. RHD variants in Flanders, Belgium. Transfusion 2015;55:1411–7.
- Lucacevic Krstic J, Dajak S, Bingulac-Popovic J, Dogic V, Mratinovic-Mikulandra J. Anti-D reagents should be chosen accordingly to the prevalence of D variants in the obstetric population. J Clin Lab Anal 2018;32:e22285.
- Safic Stanic H, Kruhonja Galic Z, Dogic V, Bingulac-Popovic J, Jukic I. Serological and molecular characterisation of the most prevalent weak D variants in Croatian population. Transfus Med 2023;33:132–6.
- Xhetani M, Seferi I, Férec C, Zoraqi G, Fichou Y. Distribution of Rhesus blood group antigens and weak D alleles in the population of Albania. Blood Transfus 2014;12:565–9.
- Koutsouri T, Chaikali A, Giannopoulos A, et al. Frequency distribution of RHD alleles among Greek donors with weak D phenotypes demonstrates a distinct pattern in central European countries. Transfus Med 2019;29:468–70.
- Yanasik M, Oguz FS, Besisik SK, et al. Frequency of RHD variants in serologically weak D Turkish blood donors. Transfus Apher Sci 2021;60:103024.
- Oodi A, Daneshvar Z, Goudarzi S, Amirizadeh N. RHD genotyping of serological weak D phenotypes in the Iranian blood donors and patients. Transfus Apher Sci 2020;59:102870.
- El Housse H, El Wafi M, Ouabdelmoumene Z, et al. Comprehensive phenotypic and molecular investigation of RhD and RhCE variants in Moroccan blood donors. Blood Transfus 2019;17:151–6.
- Ouchari M, Srivastava K, Romdhane H, Yacoub SJ, Flegel WA. Transfusion strategy for weak D type 4.0 based on RHD alleles and RH haplotypes in Thnisia. Transfusion 2018;58:306–12.
- Hussein E, Teruya J. Weak D types in the Egyptian population. Am J Clin Pathol 2013;139:806–11.
- Abdelrazik AM, Elshafie SM, Ahmed GME, Abdelaziz HM. Combining serology and molecular typing of weak D role in improving D typing strategy in Egypt. Transfusion 2013;53:2940–4.
- Maryam DU, Mukhtar IG, Yusuf AA, Salisu AL High prevalence of serological weak D phenotype and preponderance of weak D type 4.0.1. genetic variant in a Nigerian population: implications for transfusion practice in a resource-limited setting. Hematol Transfus Cell Ther 2022;44:386–91.
- Cruz BR, Chiba AK, Moritz E, Bordin JO. RHD alleles in Brazilian blood donors with weak D or D-negative phenotypes. Transfus Med 2012;22:84-9.
- Dezan MR, Oliviera VB, Nunes Gomes Q, et al. High frequency of variant RHD genotypes among donors and patients of mixed origin with serologic weak-D phenotype. J Clin Lab Anal 2018;32:e22596.
- Person RDM, Arnoni CP, Muniz JG, et al. Serologic strategy in detecting RHD altered alleles in Brazilian blood donors. Hematol Transfus Cell Ther 2020;42:365–72.
- Rodrigues ES, Romagnoli AC, Santos FLS, et al. Frequency and characterization of RHD variant alleles in a population of blood donors from southeastern Brazil: comparison with other populations. Transfus Apher Sci 2021;60:103135.
- Trucco Boggione C, Nogues N, Gonzalez-Santesteban C, et al. Characterization of RHD locus polymorphism in D negative and D variant donors from Northwestern Argentina. Transfusion 2019;59:3236-42.
- Aburto A, Zapata D, Retamales E, et al. Genotype analysis to clarify RhD variants in discrepant samples of Chilean population. Front Immunol 2023;14:1299639.
- Khetan D, Verma A, Chaudhary RK, Shukla JS. Molecular characterisation of RhD variants in North Indian blood donor population. Transfus Med 2020;30:295-303.
- Mishra G, Sachan D, Krishna D, Parchure D, Madkaikar M, Kulkami S. Characterising Indian RhD variants by serological and molecular methods. Transfus Med 2020;30:324-6.
- Zhang X, Li G, Zhou Z, et al. Molecular and computational analysis of 45 samples with a serologic weak D phenotype detected among 132,479 blood donors in northeast China. J Transl Med 2019:17:393.
- Ye L, Li M, Yang Q, Zhu Z. RHD alleles contributing to serologically weak D phenotypes in China: a single-centre study over 10 years. Vox Sang 2022;117:949-57.
- Chung YN, Kim TY, Yu H, Bae JC, Cho D. Molecular basis of serological weak D phenotypes and RhD typing discrepancies identified in the Korean population. Blood Transfus 2021; 19:327-34.
- Isa K, Sasaki K, Ogasawara K, et al. Prevalence of RHD alleles in Japanese individuals with weak D phenotype: identification of 20 new RHD alleles. Vox Sang 2016;111:315-9.
- McGowan EC, Lopez GH, Knauth CM, et al. Diverse and novel RHD variants in Australian blood donors with a weak D phenotype: implication for transfusion management. Vox Sang 2017;112:279–87.
- Schoeman EM, Roulis EV, Perry MA, Flower RL, Hyland CA. Comprehensive blood group antigen profile predictions for Western Desert Indigenous Australians from whole exome sequence data. Transfusion 2019;59:768-78.
- Jadhao S, Davison C, Roulis E, et al. Genomic characterisation of clinically significant blood group variants in Aboriginal Australians. Blood Transfus 2024;22:464-74.
- Takasaki K, Friedman DF, Uter S, Vege S, Westhoff CM, Chou ST. Variant RHD alleles and Rh immunization in patients with sickle cell disease. Br J Haematol 2023;201:1220–8.
- Chang T, Haupfear KM, Yu J, et al. A novel algorithm comprehensively characterizes human RH genes using whole- genome sequencing data. Blood Adv 2020;4:4347-57.
- Silvy M, Tournamille C, Babinet J, et al. Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti-Rh linked to partial Rh phenotype. Haematologica 2014;99:ell6.
- Hui YMT, Gurung K, Layton DM, Ibidapo M, Grimsley S, Regan F. Sickle cell disease patients in two London trusts: genotyping including RH variants. Transfus Med 2022;32:210-20.
- Desay K, Hill O, Tovey S, Finning K. Red blood cell genotyping to reduce alloimmunization and improve blood selection for haemoglobinopathy patients. Transfus Med 2016;26(Suppl 2):21. Available from https://www.bbts.org.uk/downloads/bbts2016/presentations/09.00friqs3bbts2016karendesav.l.pdf. Accessed 26 May 2025.
- Muniz JG, Arnoni C, Medeiros R, et al. Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization. Transfusion 2021;61:2458-67.
- Teles B, Santos T, Castilho L. Risk of clinically significant anti-D in sickle cell disease patients with partial D transfused with D-positive red blood cells. Vox Sang 2023;118(Suppl 1):263.
- Shih AW, Yan MTS, Elahie AL, et al. Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk. Transfus Med 2020;30:263-74.
- Leiva-Torres GA, Cigna M, Constanzo-Yanez J, et al. Transfusing children with sickle cell disease using blood group genotyping when the pool of Black donors is limited. Transfusion 2024;64:716-26.
- Reid ME, Hipsky CH, Hue-Roye K, Hoppe C. Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease. Blood Cell Mol Dis 2014;52:195-202.
- Chou ST, Evans P, Vege S, et al. RH genotype matching for transfusion support in sickle cell disease. Blood 2018;132: 1198-207.
- Wheeler MM, Lannert KW, Huston H, et al. Genomic characterization of the RH locus detects complex and novel structural variation in multi-ethnic cohorts. Genet Med 2019;21:477-86.
- Israelyan N, Vege S, Friedman DF, et al. RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: a multisite study in the USA. Transfusion 2024;64:526-35.
- Macedo MD, Miranda MR, Santos TD, Leal I, Castilho L. Rh antibodies as a result of altered Rh epitopes on transfused red cells: a case series of seven Brazilian patients. Blood Transfus 2021;19:413-9.
- Kirkegaard J, Rahorst L, Burgos A, et al. Evidence that donors with variant RH genotypes are associated with unexpected Rh antibodies. Transfusion 2023;63:1962-8.
- Chou ST, Mewha J, Friedman DF, et al. Genotyped RhD+ red cells for D-positive patients with sickle cell disease with conventional RHD and unexpected anti-D. Blood 2024; 144:2045-9.
- American College of Obstetricians and Gynecologists. Paternal and fetal genotyping in the management of alloimmunization in pregnancy. Obstet Gynecol 2024;144:e47-9.
- Pirelli KJ, Pietz BC, Johnson ST, Pinder HL, Bellissimo DB. Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D. Prenat Diagn 2010;30:1207-12
- Sillence KA, Halawani AJ, Tounsi WA, et al. Rapid RHD zygosity determination using digital PCR. Clin Chem 2017; 63:1388-97.
- Stef M, Fennell K, Apraiz I, et al. RHgenotyping by nonspecific quantitative next-generation sequencing. Transfusion 2020; 60:2691-701.
- Petch S, Crosby D. Updates in preimplantation genetic testing (PGT). Best Pract Res Clin Obstet Gynaecol 2024;96:102526.
- Moise KJ, Abels EA. Management of red cell alloimmunization in pregnancy. Obstet Gynecol 2024;144:465-80.
- Seeho SKM, Burton G, Leigh D, Marshall JT, Persson JW, Morris JM. The role of preimplantation genetic diagnosis in the management of severe rhesus alloimmunization: first unaffected pregnancy: case report. Hum Reprod 2005;20:697-701.
- Verlinsky Y, Rechitsky S, Ozen S, Masciangelo C, Ayers J, Kuliev A. Preimplantation genetic diagnosis for the Kell genotype. Fertil Steril 2003;80:1047-51.
- Altarescu G, Geva TE, Grisaru-Granovsky S, et al. Preimplantation genetic diagnosis for fetal neonatal alloimmune thrombocytopenia due to antihuman platelet antigen maternal antibodies. Obstet Gynecol 2012;119:338-43.
- Clausen FB. Antenatal RHD screening to guide antenatal anti-D immunoprophylaxis in non-immunized D-pregnant women. Immunohematology 2024;40:15-27.
- Mateus-Nino JF, Wynn J, Wiggins-Smith J, et al. Clinical performance of cell-free DNA for fetal RhD detection in RhD- negative pregnant individuals in the US. Obstet Gynecol 2025;145:402-8.
- Thompson MG, Xu W, Moore B, et al. Clinical validation of a prenatal cell-free DNA screening test for fetal RHD in a large U.S. cohort. Obstet Gynecol 2025;145:211-6.
- Moise KJ. The use of free DNA for fetal RHD genotyping in the Rh-negative pregnant patient: the time has come. Am J Obstet Gynecol 2025;232:188-93.
- American College of Obstetricians and Gynecologists. Rho(D) immune globulin shortages. Practice advisory. March 2024. Available from https://www.acog.org/clinical/dinical-guidance/practice-advisorv/articles/2024/03/rhod-immune-globulin-shortages. Accessed 26 May 2025.
- Association for the Advancement of Blood & Biotherapies. Association Bulletin #24-02. Use of Rh immune globulin and considerations in the setting of supply shortages and limited availability. 15 July 2024. Available from https://www.aabb.org/news-resources/resources/association-bulletins. Accessed 26 May 2025.
- Levine P, Rosenfield RE, White J. The first example of the Rh phenotype rGrG. Am J Hum Genet 1961;13:299-305.
- Issitt PD. Serology and genetics of the Rhesus blood group system. Cincinnati, OH: Montgomery Scientific, 1979:1.
- Pierce SR, Reid ME. Bloody brilliant: a history of blood groups and blood groupers. Bethesda, MD: AABB Press, 2016:253.